PEOPLE - Programme managers at new UK Centre for Evidence-based Purchasing
This article was originally published in Clinica
Paul Garden, Martin Glasspool and Stephen Harbron are to manage the medical device evaluation programme of the UK's new Centre for Evidence-based Purchasing. From today, the CEP replaces the Device Evaluation Service, following its transfer from the Medicines and Healthcare products Regulatory Agency (MHRA) to the Purchasing and Supply Agency (PaSA). Sue Wilkin continues as head of the service.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.